The pathogenesis of, and pharmacological treatment for, Canavan disease

H Wei, JR Moffett, M Amanat, A Fatemi… - Drug Discovery …, 2022 - Elsevier
Highlights•Canavan disease (CD) is an inherited leukodystrophy resulting from mutations in
the ASPA gene.•ASPA deficiency results in severe dysmyelination and a failure of normal …

Wnt and lithium: a common destiny in the therapy of nervous system pathologies?

D Meffre, J Grenier, S Bernard, F Courtin… - Cellular and Molecular …, 2014 - Springer
Wnt signaling is required for neurogenesis, the fate of neural progenitors, the formation of
neuronal circuits during development, neuron positioning and polarization, axon and …

Deep mutational scanning reveals a correlation between degradation and toxicity of thousands of aspartoacylase variants

M Grønbæk-Thygesen, V Voutsinos… - Nature …, 2024 - nature.com
Unstable proteins are prone to form non-native interactions with other proteins and thereby
may become toxic. To mitigate this, destabilized proteins are targeted by the protein quality …

Substrate translocation and inhibition in human dicarboxylate transporter NaDC3

Y Li, J Song, V Mikusevic, JJ Marden… - Nature Structural & …, 2024 - nature.com
The human high-affinity sodium–dicarboxylate cotransporter (NaDC3) imports various
substrates into the cell as tricarboxylate acid cycle intermediates, lipid biosynthesis …

Canavan disease, a rare early-onset human spongiform leukodystrophy: insights into its genesis and possible clinical interventions

MH Baslow, DN Guilfoyle - Biochimie, 2013 - Elsevier
The brain contains high concentrations of the amino acid N-acetyl-l-aspartate (NAA) and its'
glutamate adduct N-acetyl-l-aspartylglutamate (NAAG), both synthesized primarily by and …

Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease

JS Francis, V Markov, P Leone - Journal of inherited metabolic disease, 2014 - Springer
The inherited pediatric leukodystrophy Canavan disease is characterized by dysmyelination
and severe spongiform degeneration, and is currently refractory to treatment. A definitive …

Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease

M Grønbæk-Thygesen, R Hartmann-Petersen - Cell & Bioscience, 2024 - Springer
Canavan disease is an autosomal recessive and lethal neurological disorder, characterized
by the spongy degeneration of the white matter in the brain. The disease is caused by a …

A practical approach to diseases affecting dentate nuclei

S Khadilkar, S Jaggi, B Patel, R Yadav, P Hanagandi… - Clinical Radiology, 2016 - Elsevier
Highlights•Dentate nuclei are affected in leukodystrophies, metabolic, toxic,
neurodegenerative, inflammatory and infectious diseases.•A number of these diseases are …

Non-genetic therapeutic approaches to Canavan disease

RB Roscoe, C Elliott, A Zarros, GS Baillie - Journal of the neurological …, 2016 - Elsevier
Canavan disease (CD) is a rare leukodystrophy characterized by diffuse spongiform white
matter degeneration, dysmyelination and intramyelinic oedema with consequent impairment …

Urine N-Acetylaspartate Distinguishes Phenotypes in Canavan Disease

A Nagy, F Eichler, A Bley, J Bredow, A Fay… - Human Gene …, 2024 - liebertpub.com
Canavan disease (CD) is an ultra-rare autosomal recessive leukodystrophy caused by loss-
of-function mutations in ASPA, which encodes aspartoacylase (ASPA), leading to …